High-intensity corneal collagen crosslinking with riboflavin and UVA in rat cornea.
Ontology highlight
ABSTRACT: Corneal collagen cross-linking (CXL) halts human corneal ectasias progression by increasing stromal mechanical stiffness. Although some reports describe that this procedure is effective in dealing with some infectious and immunologic corneal thinning diseases, there is a need for more animal models whose corneal thickness more closely resemble those occurring in these patients. To meet this need, we describe here high-intensity protocols that are safe and effective for obtaining CXL in rat corneas. Initially, a range of potentially effective UVA doses were evaluated based on their effectiveness in increasing tissue enzymatic resistance to dissolution. At UVA doses higher than a threshold level of 0.54 J/cm2, resistance to enzymatic digestion increased relative to that in non-irradiated cor
SUBMITTER: Zhu Y
PROVIDER: S-EPMC5482453 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
ACCESS DATA